Aleksandar Dimovski
- Genetics top 1%
- Hemoglobinopathies and Related Disorders 24
- Chronic Lymphocytic Leukemia Research 10
- Hematology top 2%
- Iron Metabolism and Disorders 18
- Acute Myeloid Leukemia Research 6
- Biochemistry top 10%
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 12
-
- Drug Transport and Resistance Mechanisms 11
-
- Glutathione Transferases and Polymorphisms 7
-
- Lipoproteins and Cardiovascular Health 6
- Co-authors
- C. ÖnerKD LanclosNadica Matevska-GeshkovskaZorica Arsova‐SarafinovskaYC GuT. H. J. HuismanDimitar G. EfremovAhmet Aydın
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (8 papers)Blood (16 papers)
- Partner nations
- North MacedoniaUnited StatesTürkiye
In The Last Decade
Aleksandar Dimovski
126 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 124
- Genetics 778
- Hematology 594
- Pediatrics, Perinatology and Child Health 303
- Biochemistry 66
- Pharmacology 85
Countries citing papers authored by Aleksandar Dimovski
This map shows the geographic impact of Aleksandar Dimovski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksandar Dimovski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksandar Dimovski more than expected).
Fields of papers citing papers by Aleksandar Dimovski
This network shows the impact of papers produced by Aleksandar Dimovski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksandar Dimovski. The network helps show where Aleksandar Dimovski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aleksandar Dimovski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 14 | |
| 5 | 2019 | 4 | |
| 6 | 2018 | 1 | |
| 7 | 2017 | 25 | |
| 8 | 2016 | 17 | |
| 9 | 2016 | 8 | |
| 10 | 2016 | 1 | |
| 11 | Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia. | 2013 | 8 |
| 12 | 2009 | 115 | |
| 13 | 2009 | 22 | |
| 14 | 2008 | 3 | |
| 15 | 1994 | 18 | |
| 16 | 1993 | 22 | |
| 17 | 1993 | 64 | |
| 18 | 1993 | 11 | |
| 19 | 1991 | 38 | |
| 20 | 1991 | 5 |
About Aleksandar Dimovski
Aleksandar Dimovski is a scholar working on Genetics, Hematology and Pharmacology, having authored 134 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (24 papers), Iron Metabolism and Disorders (18 papers), Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Glutathione Transferases and Polymorphisms (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Genetics (778 citations), Hematology (594 citations) and Pediatrics, Perinatology and Child Health (303 citations). Aleksandar Dimovski has collaborated with scholars based in North Macedonia, United States and Türkiye. Frequent co-authors include C. Öner, KD Lanclos, Nadica Matevska-Geshkovska, Zorica Arsova‐Sarafinovska, YC Gu, T. H. J. Huisman, Dimitar G. Efremov, Ahmet Aydın, Ahmet Sayal and Onur Erdem. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.